Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GENOVEFA A PAPANICOLAOU

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1497726301
CMS profile
248991
Location
NEW YORK, NY

General Payments · PY2018–2024

$160,977.93

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$43,162.10

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,030.22 29
PY2019 $29,535.76 55
PY2020 $12,345.50 8
PY2021 $18,751.25 9
PY2022 $18,008.15 11
PY2023 $30,144.95 18
PY2024 $43,162.10 26

Payment records · PY2024 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $256.50 03/06/2024 Consulting Fee Undisputed 01/23/2026 1139452148 CMS
Astellas Pharma US Inc $513.00 10/31/2024 Consulting Fee Undisputed 01/23/2026 1139439196 CMS
AstraZeneca Pharmaceuticals LP $17.64 02/23/2024 Food and Beverage Undisputed 01/23/2026 1104507906 CMS
Janssen Research & Development, LLC $750.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1077588671 CMS
Janssen Research & Development, LLC $333.32 09/11/2024 Consulting Fee Undisputed 01/23/2026 1077588647 CMS
Merck Sharp & Dohme LLC $59.59 04/14/2024 Travel and Lodging Undisputed 01/23/2026 1141785479 CMS
Merck Sharp & Dohme LLC $290.15 04/14/2024 Travel and Lodging Undisputed 01/23/2026 1141785481 CMS
Merck Sharp & Dohme LLC $282.59 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1141785473 CMS
Merck Sharp & Dohme LLC $11,609.90 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1141785475 CMS
Merck Sharp & Dohme LLC $290.15 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1141785477 CMS
Merck Sharp & Dohme LLC $254.29 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1141740329 CMS
Merck Sharp & Dohme LLC $254.29 04/27/2024 Travel and Lodging Undisputed 01/23/2026 1141740327 CMS
Merck Sharp & Dohme LLC $75.75 04/27/2024 Food and Beverage Undisputed 01/23/2026 1141880917 CMS
Merck Sharp & Dohme LLC $41.23 04/27/2024 Food and Beverage Undisputed 01/23/2026 1141934979 CMS
Merck Sharp & Dohme LLC $254.29 04/28/2024 Travel and Lodging Undisputed 01/23/2026 1141880775 CMS
Merck Sharp & Dohme LLC $11,278.80 04/28/2024 Travel and Lodging Undisputed 01/23/2026 1141960026 CMS
Merck Sharp & Dohme LLC $4,650.00 05/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141794766 CMS
Merck Sharp & Dohme LLC $150.00 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1141794768 CMS
Merck Sharp & Dohme LLC $1,627.50 05/22/2024 Consulting Fee Undisputed 01/23/2026 1141794772 CMS
Merck Sharp & Dohme LLC $53.11 07/22/2024 Travel and Lodging Undisputed 01/23/2026 1141794762 CMS
Merck Sharp & Dohme LLC $150.00 07/22/2024 Travel and Lodging Undisputed 01/23/2026 1141794764 CMS
Merck Sharp & Dohme LLC $5,580.00 07/22/2024 Consulting Fee Undisputed 01/23/2026 1141794770 CMS
Regeneron Pharmaceuticals, Inc. $670.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1114403243 CMS
Regeneron Pharmaceuticals, Inc. $670.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1114403245 CMS
Regeneron Pharmaceuticals, Inc. $1,005.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1114403247 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,045.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 1137648154 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.